Healthcare provider profile · identity verified

Kellen Hayes

Family Practice · PHOENIX, AZ · NPI 1881076974

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	442	153
Levothyroxine Sodium	Levothyroxine Sodium	340	104
Amlodipine Besylate	Amlodipine Besylate	301	107
Metformin Hcl	Metformin Hcl	235	84
Lisinopril	Lisinopril	211	80
Losartan Potassium	Losartan Potassium	172	67
Omeprazole	Omeprazole	155	48
Metoprolol Succinate	Metoprolol Succinate	143	48
Albuterol Sulfate Hfa	Albuterol Sulfate	142	43
Trazodone Hcl	Trazodone Hcl	135	42
Gabapentin	Gabapentin	131	52
Simvastatin	Simvastatin	127	47
Rosuvastatin Calcium	Rosuvastatin Calcium	123	43
Jardiance	Empagliflozin	120	27
Hydrochlorothiazide	Hydrochlorothiazide	117	39
Pantoprazole Sodium	Pantoprazole Sodium	115	45
Tramadol Hcl	Tramadol Hcl	109	31
Tamsulosin Hcl	Tamsulosin Hcl	103	35
Furosemide	Furosemide	99	37
Prednisone	Prednisone	94	62
Alprazolam	Alprazolam	92	29
Famotidine	Famotidine	79	38
Sertraline Hcl	Sertraline Hcl	72	31
Fluticasone Propionate	Fluticasone Propionate	70	32
Ozempic	Semaglutide	64	16
Allopurinol	Allopurinol	63	19
Montelukast Sodium	Montelukast Sodium	63	21
Lovastatin	Lovastatin	60	16
Metoprolol Tartrate	Metoprolol Tartrate	59	29
Alendronate Sodium	Alendronate Sodium	58	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	58	13
Fluoxetine Hcl	Fluoxetine Hcl	55	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	55	16
Citalopram Hbr	Citalopram Hydrobromide	54	16
Donepezil Hcl	Donepezil Hcl	54	17
Eliquis	Apixaban	54	16
Finasteride	Finasteride	52	17
Naproxen	Naproxen	51	24
Glipizide	Glipizide	50	12
Lorazepam	Lorazepam	50	11
Potassium Chloride	Potassium Chloride	50	19
Atenolol	Atenolol	49	19
Carvedilol	Carvedilol	49	14
Pravastatin Sodium	Pravastatin Sodium	46	14
Tizanidine Hcl	Tizanidine Hcl	46	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	43	suppressed
Clopidogrel	Clopidogrel Bisulfate	41	17
Duloxetine Hcl	Duloxetine Hcl	39	18
Propranolol Hcl	Propranolol Hcl	39	suppressed
Baclofen	Baclofen	36	19
Zolpidem Tartrate	Zolpidem Tartrate	36	suppressed
Bupropion Hcl Sr	Bupropion Hcl	35	12
Ropinirole Hcl	Ropinirole Hcl	35	13
Amitriptyline Hcl	Amitriptyline Hcl	34	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	26
Januvia	Sitagliptin Phosphate	34	suppressed
Symbicort	Budesonide/Formoterol Fumarate	34	suppressed
Fluconazole	Fluconazole	33	12
Hydralazine Hcl	Hydralazine Hcl	31	15
Lantus	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	29	21
Metformin Hcl Er	Metformin Hcl	29	11
Escitalopram Oxalate	Escitalopram Oxalate	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	13
Ondansetron Odt	Ondansetron	27	17
Celecoxib	Celecoxib	26	suppressed
Valsartan	Valsartan	26	suppressed
Trulicity	Dulaglutide	25	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	12
Ezetimibe	Ezetimibe	23	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Fenofibrate	Fenofibrate	23	suppressed
Folic Acid	Folic Acid	23	suppressed
Glipizide Er	Glipizide	23	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	22	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Ipratropium Bromide	Ipratropium Bromide	21	17
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Cephalexin	Cephalexin	20	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Promethazine Hcl	Promethazine Hcl	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	19	suppressed
Estradiol	Estradiol	19	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	19	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Clonazepam	Clonazepam	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	13
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Nexium	Esomeprazole Magnesium	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	16	suppressed
Diazepam	Diazepam	16	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	11
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Emflaza	Deflazacort	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Clindamycin Hcl	Clindamycin Hcl	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	11
Fenofibrate	Fenofibrate,micronized	13	suppressed
Nystatin	Nystatin	13	suppressed
Pimozide	Pimozide	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Temazepam	Temazepam	13	suppressed
Topiramate	Topiramate	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Glimepiride	Glimepiride	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Linzess	Linaclotide	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Tadalafil	Tadalafil	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error